PLRX
Pliant Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.55 / 10
Netural
Analyst coverage is sparse—only one report exists, rating the stock Neutral—and historical performance for that analyst is mixed (33% win-rate). Meanwhile, fund-flow metrics paint a brighter picture: a 7.71/10 score with good overall inflow ratios across block, medium, and large sizes, hinting at underlying institutional interest despite the neutral sentiment.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-07
InstitutionRBC Capital
Times predicted3
Historical Win Rate33.3%
Is money flowing into or out of PLRX?
- PLRX holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.55/10 (Netural).
